Literature DB >> 7843755

Renal effects of acute amino acid infusion in hypertension induced by chronic nitric oxide blockade.

C Qiu1, K Engels, L Samsell, C Baylis.   

Abstract

L-Arginine is the physiological substrate of nitric oxide, a vasodilator that controls blood pressure and renal hemodynamics in the basal state. In the present studies, we produced chronic nitric oxide blockade by oral administration of the L-arginine analogue NG-nitro-L-arginine methyl ester, which produced sustained hypertension and increased renal vascular resistance in conscious rats. Acute excess L-arginine had little effect on blood pressure but completely normalized renal vascular resistance and increased renal plasma flow in chronically nitric oxide-blocked hypertensive rats. In contrast to L-arginine, D-arginine had no renal hemodynamic effects in either normal or chronically nitric oxide-blocked rats. Acutely administered glycine was ineffective in vasodilating the chronically nitric oxide-blocked rat kidney, in a dose that produced renal vasodilation in normal rats. These findings indicate the following: (1) Hypertension induced by chronic nitric oxide blockade due to substituted L-arginine analogue cannot be acutely reversed with excess L-arginine, suggesting that the maintenance of the hypertension is not solely caused by competitive inhibition of nitric oxide production; (2) in contrast, the kidney remains responsive to L-arginine whereas the renal vasodilator response to glycine is abolished in this model of hypertension.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7843755     DOI: 10.1161/01.hyp.25.1.61

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

1.  Basal and stimulated nitric oxide in control of kidney function in the aging rat.

Authors:  C Hill; A M Lateef; K Engels; L Samsell; C Baylis
Journal:  Am J Physiol       Date:  1997-06

2.  HIF isoforms in the skin differentially regulate systemic arterial pressure.

Authors:  Andrew S Cowburn; Norihiko Takeda; Adam T Boutin; Jung-Whan Kim; Jane C Sterling; Manando Nakasaki; Mark Southwood; Ananda W Goldrath; Colin Jamora; Victor Nizet; Edwin R Chilvers; Randall S Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

Review 3.  Chronic nitric oxide inhibition model six years on.

Authors:  R Zatz; C Baylis
Journal:  Hypertension       Date:  1998-12       Impact factor: 10.190

4.  PPAR-gamma agonist rosiglitazone reverses increased cerebral venous hydraulic conductivity during hypertension.

Authors:  Tim J M Roberts; Abbie C Chapman; Marilyn J Cipolla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-07       Impact factor: 4.733

5.  Dexamethasone worsens nitric oxide inhibition-induced hypertension and renal dysfunction.

Authors:  C Qiu; C Baylis
Journal:  Am J Hypertens       Date:  2000-10       Impact factor: 2.689

6.  Hypertension and impaired glycine handling in mice lacking the orphan transporter XT2.

Authors:  Hui Quan; Krairerk Athirakul; William C Wetsel; Gonzalo E Torres; Robert Stevens; Y T Chen; Thomas M Coffman; Marc G Caron
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.